~~<i id='E92D6E30F2'><strike id='E92D6E30F2'><tt id='E92D6E30F2'><pre id='E92D6E30F2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：comprehensive 2025-09-29 22:48:29 - browse：1

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FDA official pushes for dedicated emerging pathogens team

hotspot

knowledge

entertainment

Wikipedia

hotspot

entertainment

AdobeTRENTON,N.J.—PharmaindustrygiantsincludingBristolMyersSquibb,Johnson&Johnson,Novartis,andNo

WSS

Marvel Studios reveals new trailer for 'The Marvels': Watch here

AbbVie dramatically boosts its spending on lobbying

Organ transplantation is at a crossroads. Major reform is needed

First over

CDC backtracks, saying fully vaccinated people can go maskless indoors

Artificial intelligence advances fuel industry trying to preserve loved ones after death

focus

comprehensive

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

What to know about Saharan dust affecting the US and how it can affect health

Medical records are filled with copy

State of the Union pitch: Bigger Medicare drug price negotiations

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

IVF doctors demand details after CooperSurgical lawsuit

Jerome Adams on the need for new antivirals for Covid

$1 billion proposal to grow Boston, Massachusetts biotech

Continuity nursing helped my family in our darkest PICU moments

Providers still hesitate to prescribe buprenorphine, study finds

knowledge

Longer MASH drug regimen improved liver, Akero study finds

Review: 'Barbie' will hit you like a shot in the heart

Fetal cell organoids grown from amniotic fluid, study finds

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Ozempic has benefits for kidney disease as well as diabetes

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

entertainment

Wikipedia

hotspot

entertainment